They are well-positioned to penetrate markets inaccessible to injectable formulations and are expected to become the next-generation standard of care in metabolic disease management
doi: 10.3389/fphar.2024.1491249 Received 04 September 2024 Accepted 14 November 2024 Published 02 December 2024 Volume 15 - 2024 Edited by Anna Maria Giudetti, University of Salento, Italy Reviewed by Daniele Vergara, University of Salento, Italy Azza Awad, Al-Azhar University, Egypt Updates Copyright 2024 Mahmoud, Elshazly, El-shaarawy, Zaitone, Aldahish, Ahmed, Fawzy, Aloyouni, Abed, Saeedi and El-Sayed
In addition, theres the practical question of location: where would a GLP-1 range sit
La falta de esta molcula tambin puede deberse a componentes genticos que provocan problemas en su sntesis, malabsorcin intestinal o problemas hepticos